Document is current
Any future updates will be listed below
-
Authors
Kario, Kazuomi
Kai, Hisashi
Rakugi, Hiromi
Hoshide, Satoshi
Node, Koichi
Maekawa, Yuichiro
Tsutsui, Hiroyuki
Sakata, Yasushi
Aoki, Jiro
Nanto, Shinsuke
Yokoi, Hiroyoshi
- License Information
-
More Information
Article History
Received: 9 April 2024
Accepted: 12 April 2024
First Online: 26 July 2024
Compliance with ethical standards
:
: Kario K receives grants from A&D, Omron Healthcare, Fukuda Denshi, CureApp, Sanwa Kagaku Kenkyusho; Honoraria from Daichi Sankyo, Viatris, Novartis, Otsuka Pharmaceuticals, Medtronic, Otsuka Medical device, Omron Healthcare. Kai H receives honoraria from Daiichi Sankyo, Novartis and Otsuka Medical Device. Rakugi H receives honoraria from Daiichi Sankyo Co., Ltd., Novartis Pharma K.K., and Otsuka Pharmaceutical Co., Ltd.; research funding from Novartis Pharma K.K.; scholarship from Daiichi Sankyo Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd. Takeda Pharmaceutical Company Ltd., and Sumitomo Pharma, Co., Ltd. Hoshide S receives honoraria from Novartis. Node K receives research grants from Otsuka Medical Devices, Medtronic, Astellas, Bayer Yakuhin, Boehringer Ingelheim Japan, Fujiyakuhin, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Novartis Pharma; Scholarship from Abbott, Boehringer Ingelheim Japan, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Teijin Pharma; Honoraria from AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Novo Nordisk Pharma, Ono Pharmaceutical, Otsuka, Tsumura & Co. Maekawa Y receives Scholarship funds or Donations Scholarship funds from Abbott Medical Japan LLC, and BIOTRONIK JAPAN. Tsutsui H receives consultancy from Boehringer Ingelheim Co., Ltd., Bayer Yakuhin, Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Astra-Zeneca Co., Ltd.; Remuneration from MSD K.K., Astellas Pharma Inc., Pfizer Japan Inc., Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Boehringer Ingelheim Co., Ltd., Takeda Pharmaceutical Company Limited, Bayer Yakuhin, Ltd., Novartis Pharma K.K., Kowa Pharmaceutical Co. Ltd., Teijin Pharma Ltd.; Manuscript fees from Medical View, Nippon Rinsho; Research funding from Actelion Pharmaceuticals Japan Ltd., Japan Tobacco Inc., Mitsubishi Tanabe Pharma Corporation, Nippon Boehringer Ingelheim Co., Ltd., Daiichi Sankyo Co., Ltd., IQVIA Services Japan, Omron Healthcare; Scholarship funds from Astellas Pharma Inc., Novartis Pharma K.K., Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, Teijin Pharma Ltd., MSD K.K. Sakata Y receives grants from Abbott Medical Japan, Otsuka Pharmaceutical, Nippon Boehringer Ingelheim, Boston Scientific Japan, BIOTRONIK JAPAN; Honoraria from AstraZeneca, Otsuka Pharmaceutical, Nippon Boehringer Ingelheim, Novartis Pharma and Bayer Yakuhin. Aoki J receives Honoraria from Medtronic, Otsuka Medical Device, Otsuka Pharmaceutical, and Daiichi Sankyo. Nanto S receives Honoraria from Medtronic, Otsuka Medical device. Yokoi H receives Honoraria from Daiichi-Sankyo, Medtronic, Otsuka Medical device. Role of Clinical Trials: Kario K is an Executive Committee Principal Investigator for the Spyral OFF MED, the Spyral ON MED, the DUO and the REQUIRE; a Coordinating investigator for the TCD-16164 study; a Site Principal Investigator for the HTN-J, the Spyral OFF MED, the Spyral ON MED, the DUO, the REQUIRE and the TCD-16164 study. Kai H is a Site Sub-Investigator for the HTN-J; a medical expert for the DUO and the REQUIRE. Rakugi H is a Site Sub-Investigator for the HTN-J, the DUO and the REQUIRE. Hoshide S is a Site Sub-Investigator for the HTN-J, the Spyral OFF MED, the Spyral ON MED, the DUO, the REQUIRE and the TCD-16164 study; a medical expert for the REQUIRE. Node K is a Site Sub-Investigator for the REQUIRE. Maekawa Y is a Site Principal Investigator for the DUO. Sakata Y is a Principal Investigator for the DUO and the REQUIRE; a Site Sub-Investigator for the HTN-J. Aoki J is a Site Sub-Investigator for the HTN-J; a Site Principal Investigator for the Spyral OFF MED, the Spyral ON MED studies, the DUO and the REQUIRE. Nanto S is an Executive Committee Principal Investigator for the DUO and the REQUIRE; a member of the Advisory team for Ablation Site for the REQUIRE; a Site Principal Investigator for the REQUIRE. Yokoi H is a Site Principal Investigator for the DUO, the REQUIRE and the TCD-16164 study; an Advisor on Renal Artery Access for the REQUIRE.
Free to read: This content has been made available to all.
